Power Law company profile

Tourmaline Bio

Biotech & Life Sciences · New York City, United States · Founded 2022 · IPO 2023 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$991M

Market cap · 2026

Investors

16 investors on Tourmaline Bio's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 3 investors entered at this stage

Petrichor

Hydra Ventures

QVT Financial LP

Series A 3 investors entered at this stage

Cowen Healthcare Investments

Deep Track Capital

TCGX

Series B+ 10 investors entered at this stage

Paradigm BioCapital

Qiming Venture Partners USA

Braidwell

Acuta Capital Partners

RA Capital Management

Great Point Partners

Affinity Asset Advisors

StemPoint Capital

Vivo Capital

KVP Capital

Global footprint

Where Tourmaline Bio has talent and traffic

Web traffic by country

5.5K monthly visits
across markets

🇺🇸 United States76.4%

🇮🇳 India12.7%

🇨🇦 Canada10.9%

🇧🇪 Belgium0%

Top 4 markets shown

Patent intelligence

$60k patent portfolio · 4 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$60k

<0.01% of market cap · 523.4× smaller than top peer Synthorx ($32M)

4 active patent families

Where Tourmaline Bio innovates InterleukinPharmacologyAntibody fragmentsActive agentPathology

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Tourmaline Bio on the five Patsnap quality dimensions

Tourmaline Bio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Tourmaline Bio concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Tourmaline Bio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Tourmaline Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo